The grades of 5 Pharmaceuticals stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an “A” (“strong buy”) or “B” overall (“buy”) rating.

This week, Catalent Inc (CTLT) pushes up from a C to a B rating. The company also gets A’s in return on equity and free cash flow. For more information, get Portfolio Grader’s complete analysis of CTLT stock.

RedHill Biopharma Ltd. Sponsored ADR (RDHL) gets a higher grade this week, advancing from a C last week to a B. For more information, get Portfolio Grader’s complete analysis of RDHL stock.

Tetraphase Pharmaceuticals, Inc. (TTPH) improves from a C to a B rating this week. The company also gets A’s in sales growth, earnings revisions, earnings surprise, and earnings momentum. For more information, get Portfolio Grader’s complete analysis of TTPH stock.

MediWound Ltd. (MDWD) is seeing ratings go up from a B last week to a A this week. The company also gets A’s in sales growth, earnings revisions, earnings surprise, and earnings momentum. For more information, get Portfolio Grader’s complete analysis of MDWD stock.

Teligent, Inc. (TLGT) boosts its rating from a C to a B this week. The company also gets A’s in sales growth, operating margin growth, earnings revisions, and return on equity. For more information, get Portfolio Grader’s complete analysis of TLGT stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.